Helicobacter pylori: what schemes of eradication are essential today?


Cite item

Full Text

Abstract

Current approaches to treatment of Helicobacter pylori infection, basic international recommendations, problems of growing H. pylori resistance to antibiotics are reviewed. Much attention is given to prospects of new eradication schemes, for example combinations based on bismuth tripotassium dicitrate and successive treatment schedules.

About the authors

Igor' Veniaminovich Maev

Email: igormaev@rambler.ru

Aleksey Andreevich Samsonov

Email: aleksey.samsonov@mail.com

Nikolay Nikolaevich Golubev

Email: nngolubev@mail.ru

I V Maev

State Medicostomatological University, Moscow

State Medicostomatological University, Moscow

A A Samsonov

State Medicostomatological University, Moscow

State Medicostomatological University, Moscow

N N Golubev

State Medicostomatological University, Moscow

State Medicostomatological University, Moscow

References

  1. Warren J. R., Marshall B. J. Unidentified curved bacilli on gastric epithelium in active chronic Gastritis. Lancet 1983; 1: 1273-1275.
  2. Malfertheiner P., Megraud F., O'Morain C. et al. Current concepts in the management of Helicobacter pylori infection - The Maastricht III Consensus Report. Gut 2007; 56: 772- 781.
  3. Chey W. D., Wong B. C. Y. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am. J. Gastroenterol. 2007; 102: 1808-1825.
  4. Asaka M., Kato M., Takahashi S. et al. Guidelines for the management of helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter 2010; 15: 1-20.
  5. Malfertheiner P. Bismuth improves PPI-based triple therapy for H. pylori eradication. Nat. Rev. Gastroenterol. Hepatol. 2010; 7: 538-539.
  6. Барышникова Н. В., Успенский Ю. П., Ткаченко Е. И. Оптимизация лечения больных с заболеваниями, ассоциированными с Helicobacter pylori: обоснование необходимости использования препаратов висмута. Экспер. и клин, гастроэнтерол. 2009; 6: 116-121.
  7. Graham D. Y., Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 2010; 59: 1143-1153.
  8. Malfertheiner P., Megraud F. Quadruple therapy with bismuth subcitrate potassium, metronidazole, tetracycline, and omeprazole is superior to triple therapy with omeprazole, amoxicillin, and clarithromycin in the eradication of helicobacter pylori. Gastroenterology 2010; 138 (Suppl. 1): S-33.
  9. Захарова Н. В. Пути повышения эффективности и безопасности схем эрадикации Helicobacter pylori. Рос. журн. гастроэнтерол., гепатол., колопроктол. 2006; 3: 45-51.
  10. Самсонов А. А. Антибиотики схем эрадикации Helicobacter pylori. Чем мы ограничены в выборе препаратов? Рос. журн. гастроэнтерол., гепатол., колопроктол. 2008; 4: 63-68.
  11. De Francesco V., Margiotta M., Zullo A. et al. Prevalence of primary clarithromycin resistance in Helicobacter pylori strains over a 15 year period in Italy. J. Antimicrob. Chemother. 2007; 59: 783-785.
  12. Megraud F. H. pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004; 53: 1374-1384.
  13. Корниенко Е. А., Паролова Н. И. Антибиотикорезистентность Helicobacter pylori у детей и выбор терапии. Вопр. соврем. педиатр. 2006; 5: 46-50.
  14. Кудрявцева Л. В. Биологические свойства Helicobacter pylori. В кн.: Альманах клинической медицины. М.; 2006; т. 14: 39-46.
  15. Жебрун А. Б., Сварваль А. В., Ферман Р. С. Исследование антибиотикорезистентности штаммов H. pylori, циркулирующих в Санкт-Петербурге в современный период. Клин, микробиол. и антимикроб. химиотер. 2008; 2 (прил. 1): 18-19.
  16. Барышникова Н. В., Денисова Е. В., Корниенко Е. А. и др. Эпидемиологическое исследование резистентности Helicobacter pylori к кларитромицину у жителей Санкт-Петербурга с язвенной болезнью. Экспер. и клин. гастроэнтерол. 2009; 5: 73-76.
  17. Fischbach L., Evans E. L. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori. Aliment. Pharmacol. Ther. 2007; 26: 343-357.
  18. Treiber G., Ammon S., Malfertheiner P., Klotz U. Impact of furazolidone-based quadruple therapy for eradication of Helicobacter pylori after previous treatment failures. Helicobacter 2002; 7: 225-231.
  19. Fischbach L. A., van Zanten S., Dickason J. Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies. Aliment. Pharmacol. Ther. 2004; 20: 1071-1082.
  20. Sun Q., Liang X., Zheng Q. et al. High efficacy of 14-Day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication. Helicobacter 2010; 15: 233-238.
  21. Афанасьева Т. С., Перевозщикова Е. Э., Вахрушев Я. М. Клиническая эффективность Де-нола у больных язвенной болезнью. Экспер. и клин. гастроэнтерол. 2008; 4: 31-34.
  22. Стандарты диагностики и лечения кислотозависимых и ассоциированных с Helicobacter pylori заболеваний (Четвертое московское соглашение). Экспер. и клин. гастроэнтерол. 2010; 5: 113-118.
  23. Vaira D., Zullo A., Vakil N. et al. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial. Ann. Intern. Med. 2007; 146: 556- 563.
  24. Jafri N. S., Hornung C. A., Howden C. W. Meta-analysis: Sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment. Ann. Intern. Med. 2008; 148: 923-931.
  25. Лапина Т., Коньков М., Ивашкин В. и др. Отдаленные результаты эрадикационной терапии Н. pylori при атрофическом гастрите. Врач 2009; 3:47-50.
  26. Vakil N., Megraud F. Eradication therapy for Helicobacter pylori. Gastroenterology 2007; 133: 985-1001.
  27. Gisbert J. P., Gisbert J. L., Marcos S. et al. Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two, Helicobacter pylori treatment failures. Aliment Pharmacol. Ther, 2006; 24: 1469-1474.
  28. Giannini E. G., Bilardi C., Dulbecco P. et al. A study of 4- and 7-day triple therapy with rabeprazole, high-dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication. Aliment. Pharmacol. Ther. 2006; 23: 281-287.
  29. Cammarota G., Martino A., Pirozzi G. et al. High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection. Aliment. Pharmacol. Ther. 2004; 19: 789-795.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2011 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies